Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.

Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.

MENTIONED STOCKS

More Top Stories News

Money-saving habits to cope with higher prices — from our readers

Time for a Micron mindset shift? Here’s how to navigate the new AI landscape.

AI stocks are probably in a bubble — but might be worth holding on to, says Citadel’s Ken Griffin

Polymarket traders see a 10% chance the AI bubble bursts before New Year’s Day

We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?

Content sourced from MarketWatch. Not financial advice.